跳至主要内容
临床试验/NL-OMON21819
NL-OMON21819已完成Unknown

Fully closed loop glucose Regulation; Evidence and Experience in real life

Inreda Diabetic BV0 个研究点目标入组 82 人开始时间: 待定最近更新:
适应症

试验速览

阶段
Unknown
状态
已完成
入组人数
82

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 64(—)

入选标准

  • - Clinically planning to and be able to start with the AP of Inreda Diabetic; - Treatment with continuous glucose monitoring (CGM) or flash glucose monitoring (FGM) for at least 3 months prior to AP treatment; - Receive treatment in one of the participating centers; - Willing and able to sign informed consent.

排除标准

  • - Planning to become pregnant during the follow-up period; - Any condition that the local investigator feels would interfere with trial participation or the evaluation of the results.

研究者

相似试验